BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02387957-completion@plaintrial.com
DTSTAMP:20260926T055246Z
DTSTART;VALUE=DATE:201701
SUMMARY:A 24 Month Phase 2a Open Label\, Randomized Study of Avastin®\, Lu
 centis®\, or Eylea® (Anti-VEGF Therapy) Administered in Combination With
  Fovista® (Anti-PDGF BB Pegylated Aptamer) — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02387957
URL:https://plaintrial.com/trial/NCT02387957
END:VEVENT
END:VCALENDAR